Speciality: Hematology
Description:
Welcome to our podcast. Today, we're exploring the vital role of platelets in normal blood clotting. Platelets are tiny cell fragments in our blood, often called thrombocytes. When you get a cut or injury, platelets rush to the site and stick together, forming a temporary plug to stop bleeding. They also release chemicals that help activate other clotting factors, creating a stable blood clot. This process is essential to prevent excessive blood loss and support healing. If platelet counts are too low or their function is impaired, even minor injuries can cause serious bleeding. Understanding platelets helps us appreciate how our bodies protect us every day. Stay tuned for more insights into the amazing world of human biology.
See More Webinars @ Hidoc Webinars
1.
Adjuvant Tx May Boost Survival in Bilateral Breast Cancer
2.
Lower screening age calls for more tailored bowel cancer surveillance
3.
Study identifies new approach to protect the brain during radiation therapy
4.
Research exposes far-reaching toll of financial hardship on patients with cancer
5.
Q&A: Breast cancer facts that could save lives
1.
Revolutionizing Cancer Care: The Impact of Darzalex Faspro
2.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
3.
Clinical Pharmacology of Erythropoiesis-Stimulating Pathway Modulators
4.
Exploring New Treatment Strategies for Mantle Cell Lymphoma
5.
Managing High Potassium Levels: A Comprehensive Guide to Veltassa
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the causes of anemia in adults beyond nutritional deficiencies
2.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
3.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation